Over 30% of our work is focused on progressing critical cancer research.

Despite the significant advances made in finding treatments for human diseases, there remains an unmet need in oncology research. Approximately one-third of Everest’s clinical research projects are trials for cancer treatments.

Diverse and deep oncology experience. Oncology clinical research development is a passion and an area of strong expertise of Everest. We pride ourselves on establishing longstanding experienced teams to help advance the research for various cancers that afflicts the global community. While Everest has worked across 26 therapeutic areas including central nervous system (CNS), medical aesthetics, infectious diseases, vaccines, rare diseases, respiratory, dermatology, and gastroenterology among others, we are proud to have a deep oncology focus, having delivered or are actively supporting 175+ oncology clinical trials over the past 3 years.  

Our work in this space spans solid and liquid tumour clinical research trials across Phases I, II, III, and IV, being conducted in North America and across the globe. We are continually inspired as we work hand-in-hand with the world’s leading experts on the most advanced cancer therapies to bring to patients. We are accustomed to working with researchers to design and operationalize complex oncology trials, and are a trusted partner for both large top 10 global pharmaceutical companies, and many smaller and high-performing biotechnology and pharmaceutical companies. 

Our approach is predicated on quality, integrity, and adaptability to the changing needs of oncology clinical trials and we are as dedicated to the success of these trials as our clients. We ensure the Everest teams assigned bring specialized oncology experience, and all members of our senior leadership teams are involved to develop robust and pragmatic solutions to the most challenging questions.